These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17916014)
21. Type 2 polysaccharide storage myopathy in Quarter Horses is a novel glycogen storage disease causing exertional rhabdomyolysis. Valberg SJ; Williams ZJ; Finno CJ; Schultz A; Velez-Irizarry D; Henry ML; Gardner K; Petersen JL Equine Vet J; 2023 Jul; 55(4):618-631. PubMed ID: 36102343 [TBL] [Abstract][Full Text] [Related]
22. Molecular characterization and mutational screening of the PRKAG3 gene in the horse. Park HB; Marklund S; Jeon JT; Mickelson JR; Valberg SJ; Sandberg K; Andersson L Cytogenet Genome Res; 2003; 102(1-4):211-6. PubMed ID: 14970705 [TBL] [Abstract][Full Text] [Related]
23. An epidemiological study of myopathies in Warmblood horses. Hunt LM; Valberg SJ; Steffenhagen K; McCue ME Equine Vet J; 2008 Mar; 40(2):171-7. PubMed ID: 18089471 [TBL] [Abstract][Full Text] [Related]
24. Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes. Shen QW; Zhu MJ; Tong J; Ren J; Du M Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1395-403. PubMed ID: 17687000 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses. Tryon RC; Penedo MC; McCue ME; Valberg SJ; Mickelson JR; Famula TR; Wagner ML; Jackson M; Hamilton MJ; Nooteboom S; Bannasch DL J Am Vet Med Assoc; 2009 Jan; 234(1):120-5. PubMed ID: 19119976 [TBL] [Abstract][Full Text] [Related]
26. Serum creatine kinase response to exercise during dexamethasone-induced insulin resistance in Quarter Horses with polysaccharide storage myopathy. Firshman AM; Valberg SJ; Karges TL; Benedict LE; Annandale EJ; Seaquist ER Am J Vet Res; 2005 Oct; 66(10):1718-23. PubMed ID: 16273902 [TBL] [Abstract][Full Text] [Related]
27. Presence of the glycogen synthase 1 (GYS1) mutation causing type 1 polysaccharide storage myopathy in continental European draught horse breeds. Baird JD; Valberg SJ; Anderson SM; McCue ME; Mickelson JR Vet Rec; 2010 Nov; 167(20):781-4. PubMed ID: 21262610 [TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions. Barrey E; Mucher E; Jeansoule N; Larcher T; Guigand L; Herszberg B; Chaffaux S; Guérin G; Mata X; Benech P; Canale M; Alibert O; Maltere P; Gidrol X BMC Vet Res; 2009 Aug; 5():29. PubMed ID: 19664222 [TBL] [Abstract][Full Text] [Related]
29. 5'-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. Barnes BR; Glund S; Long YC; Hjälm G; Andersson L; Zierath JR FASEB J; 2005 May; 19(7):773-9. PubMed ID: 15857891 [TBL] [Abstract][Full Text] [Related]
30. [AMP-activated protein kinase: how a mistake in energy gauge causes glycogen storage]. Ofir M; Hochhauser E; Vidne BA; Freimark D; Arad M Harefuah; 2007 Oct; 146(10):770-5, 813-4. PubMed ID: 17990392 [TBL] [Abstract][Full Text] [Related]
31. Estimated prevalence of the GYS-1 mutation in healthy Austrian Haflingers. Schwarz B; Ertl R; Zimmer S; Netzmann Y; Klein D; Schwendenwein I; Hoven RV Vet Rec; 2011 Nov; 169(22):583. PubMed ID: 21949056 [TBL] [Abstract][Full Text] [Related]
32. Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. Luptak I; Shen M; He H; Hirshman MF; Musi N; Goodyear LJ; Yan J; Wakimoto H; Morita H; Arad M; Seidman CE; Seidman JG; Ingwall JS; Balschi JA; Tian R J Clin Invest; 2007 May; 117(5):1432-9. PubMed ID: 17431505 [TBL] [Abstract][Full Text] [Related]
33. Dissociation of AMP-activated protein kinase and p38 mitogen-activated protein kinase signaling in skeletal muscle. Ho RC; Fujii N; Witters LA; Hirshman MF; Goodyear LJ Biochem Biophys Res Commun; 2007 Oct; 362(2):354-9. PubMed ID: 17709097 [TBL] [Abstract][Full Text] [Related]
34. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Viollet B; Andreelli F; Jørgensen SB; Perrin C; Flamez D; Mu J; Wojtaszewski JF; Schuit FC; Birnbaum M; Richter E; Burcelin R; Vaulont S Biochem Soc Trans; 2003 Feb; 31(Pt 1):216-9. PubMed ID: 12546688 [TBL] [Abstract][Full Text] [Related]
35. Cloning and characterization of mouse 5'-AMP-activated protein kinase gamma3 subunit. Yu H; Fujii N; Hirshman MF; Pomerleau JM; Goodyear LJ Am J Physiol Cell Physiol; 2004 Feb; 286(2):C283-92. PubMed ID: 14512293 [TBL] [Abstract][Full Text] [Related]
36. Insulin sensitivity and skeletal muscle glucose transport in horses with equine polysaccharide storage myopathy. Annandale EJ; Valberg SJ; Mickelson JR; Seaquist ER Neuromuscul Disord; 2004 Oct; 14(10):666-74. PubMed ID: 15351424 [TBL] [Abstract][Full Text] [Related]
37. Thyroid hormone activates adenosine 5'-monophosphate-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-beta. Yamauchi M; Kambe F; Cao X; Lu X; Kozaki Y; Oiso Y; Seo H Mol Endocrinol; 2008 Apr; 22(4):893-903. PubMed ID: 18187603 [TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and muscle glycogen concentrations in warmblood horses with polysaccharide storage myopathy. Lewis SS; Nicholson AM; Williams ZJ; Valberg SJ Am J Vet Res; 2017 Nov; 78(11):1305-1312. PubMed ID: 29076373 [TBL] [Abstract][Full Text] [Related]
39. Bypassing the glucose/fatty acid cycle: AMP-activated protein kinase. Carling D; Fryer LG; Woods A; Daniel T; Jarvie SL; Whitrow H Biochem Soc Trans; 2003 Dec; 31(Pt 6):1157-60. PubMed ID: 14641016 [TBL] [Abstract][Full Text] [Related]